News & Insights

Gunderson Dettmer partner, Tim Ehrlich, to moderate a panel at the annual Genesis London Conference

Gunderson Dettmer Strategic Transactions and Licensing partner Brendan McCarthy hosted the webinar “’What’s Market’ in University Licenses in the Life Sciences Industry” to discuss the key economic terms in university license agreements.

RNA editing company, AIRNA, announces its $155 million Series B financing co-led by Venrock Healthcare Capital Partners and Forbion Growth

Medical technology company, Evident Vascular, announces its Series B financing from Shangbay Capital, Vensana Capital and more 

Gunderson Dettmer advises The Column Group as an investor in Surrozen’s $175 million oversubscribed private placement

Gunderson Dettmer announces the addition of Life Sciences Partner, Adrian Rich, based in the Northern California offices

Managing over 280 financings and more than $14 billion in invested capital for the most promising startups worldwide, Gunderson Dettmer was recognized as the most active law firm globally by the PitchBook Global League Tables for the third quarter in a row

Gunderson Dettmer Boston partner, Tim Ehrlich, was recognized by Massachusetts Lawyers Weekly as a Massachusetts Go To Lawyer in the health care and life sciences practice area